The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CARIBOU BIOSCIENCES INC | COM | 142038108 | 2,716,404 | 474,067 | SH | DFND | 0 | 474,067 | 0 | ||
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 2,604,534 | 172,600 | SH | DFND | 0 | 172,600 | 0 | ||
KORRO BIO INC | COM | 500946108 | 13,268,510 | 276,831 | SH | DFND | 0 | 276,831 | 0 | ||
OMEGA THERAPEUTICS INC | COMMON STOCK | 68217N105 | 1,062,352 | 352,941 | SH | DFND | 0 | 352,941 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 1,468,987 | 65,933 | SH | DFND | 0 | 65,933 | 0 | ||
TURNSTONE BIOLOGICS CORP | COM | 90042W100 | 1,399,702 | 549,981 | SH | DFND | 0 | 549,981 | 0 |